HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 247 filers reported holding HAEMONETICS CORP in Q4 2017. The put-call ratio across all filers is 1.58 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $12,747 | +109.7% | 142,300 | +99.3% | 0.02% | +144.4% |
Q2 2023 | $6,079 | +1313.7% | 71,400 | +1273.1% | 0.01% | +800.0% |
Q1 2023 | $430 | +70.6% | 5,200 | +62.5% | 0.00% | – |
Q4 2022 | $252 | -100.0% | 3,200 | -92.0% | 0.00% | -100.0% |
Q2 2022 | $2,614,000 | +87.1% | 40,100 | +81.4% | 0.00% | +50.0% |
Q1 2022 | $1,397,000 | -84.8% | 22,100 | -83.0% | 0.00% | -83.3% |
Q3 2021 | $9,162,000 | -77.1% | 129,785 | -78.4% | 0.01% | -76.0% |
Q2 2021 | $40,017,000 | -71.8% | 600,494 | -53.1% | 0.05% | -71.8% |
Q1 2021 | $142,103,000 | -24.1% | 1,280,094 | -18.8% | 0.18% | -12.8% |
Q4 2020 | $187,173,000 | +10.9% | 1,576,194 | -18.5% | 0.20% | +20.1% |
Q3 2020 | $168,758,000 | -13.9% | 1,934,185 | -11.6% | 0.17% | 0.0% |
Q2 2020 | $195,938,000 | -10.0% | 2,187,785 | +0.2% | 0.17% | -19.9% |
Q1 2020 | $217,696,000 | -22.3% | 2,184,385 | -10.5% | 0.21% | -1.9% |
Q4 2019 | $280,335,000 | -15.4% | 2,439,816 | -7.1% | 0.22% | -23.2% |
Q3 2019 | $331,357,000 | +10.8% | 2,626,900 | +5.7% | 0.28% | +6.5% |
Q2 2019 | $298,973,000 | +43.9% | 2,484,400 | +4.6% | 0.26% | +39.2% |
Q1 2019 | $207,826,000 | -14.2% | 2,375,700 | -1.8% | 0.19% | -28.7% |
Q4 2018 | $242,081,000 | -6.4% | 2,419,600 | +7.2% | 0.26% | -0.4% |
Q3 2018 | $258,550,000 | -5.4% | 2,256,500 | -31.4% | 0.27% | +78.5% |
Q2 2018 | $273,178,000 | +183.0% | 3,289,200 | +149.3% | 0.15% | +40.6% |
Q1 2018 | $96,535,000 | +70.1% | 1,319,500 | +35.0% | 0.11% | +68.3% |
Q4 2017 | $56,750,000 | +44.3% | 977,100 | +11.5% | 0.06% | +37.0% |
Q3 2017 | $39,315,000 | +8.2% | 876,207 | -4.7% | 0.05% | 0.0% |
Q2 2017 | $36,323,000 | +9.4% | 919,800 | +12.4% | 0.05% | 0.0% |
Q1 2017 | $33,211,000 | -7.7% | 818,600 | -8.6% | 0.05% | -19.3% |
Q4 2016 | $35,987,000 | +12.5% | 895,200 | +1.3% | 0.06% | 0.0% |
Q3 2016 | $31,995,000 | +42.0% | 883,600 | +13.7% | 0.06% | +32.6% |
Q2 2016 | $22,534,000 | +132.4% | 777,300 | +180.4% | 0.04% | +138.9% |
Q1 2016 | $9,696,000 | +58.5% | 277,200 | +46.1% | 0.02% | +38.5% |
Q4 2015 | $6,116,000 | -27.2% | 189,700 | -27.0% | 0.01% | -35.0% |
Q3 2015 | $8,403,000 | +338.8% | 260,000 | +461.6% | 0.02% | +400.0% |
Q2 2015 | $1,915,000 | -49.4% | 46,300 | -45.1% | 0.00% | -50.0% |
Q1 2015 | $3,787,000 | +0.8% | 84,300 | -16.0% | 0.01% | -11.1% |
Q4 2014 | $3,757,000 | +193.1% | 100,400 | +173.6% | 0.01% | +125.0% |
Q3 2014 | $1,282,000 | -83.1% | 36,700 | -82.9% | 0.00% | -77.8% |
Q2 2014 | $7,578,000 | -8.5% | 214,800 | -15.5% | 0.02% | -10.0% |
Q1 2014 | $8,285,000 | +653.2% | 254,226 | +874.0% | 0.02% | +566.7% |
Q4 2013 | $1,100,000 | -88.4% | 26,100 | -89.0% | 0.00% | -87.0% |
Q3 2013 | $9,472,000 | -2.1% | 237,500 | +1.5% | 0.02% | -8.0% |
Q2 2013 | $9,672,000 | – | 233,900 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Millrace Asset Group, Inc. | 19,264 | $1,726 | 2.13% |
Parkman Healthcare Partners LLC | 88,962 | $7,969,216 | 1.46% |
HEARTLAND ADVISORS INC | 256,414 | $24,435,274 | 1.37% |
Riverwater Partners LLC | 15,553 | $1,393,238 | 1.27% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 111,100 | $9,952,338 | 1.15% |
Lisanti Capital Growth, LLC | 78,425 | $7,025,312 | 1.11% |
Aristotle Capital Boston, LLC | 311,666 | $27,919,054 | 0.90% |
ROYCE & ASSOCIATES LP | 947,550 | $84,881,529 | 0.86% |
CHASE INVESTMENT COUNSEL CORP | 18,770 | $1,681 | 0.84% |
Virtus Investment Advisers, Inc. | 13,662 | $1,223,842 | 0.83% |